CAN:s bibliotek

*000      am a        a
*00118086
*007cr |||||||||||
*008070120s1990||||xxu||||es|||||||||1|eng||
*24510$aDrugs of abuse :$bchemistry, pharmacology, immunology, and AIDS
*260  $aRockville, Md :$bNational Institute on Drug Abuse,$c1990
*300  $a243 s :$bill.
*440  $aNIDA research monograph series ;$v96
*490  $aDHHS publication ; $v90-1676
*500  $aE-bok
*520  $aThe bivalent ligand approach in the design of highly selective opioid receptor antagonists. Opium alkaloids and affinity labels. Novel thebainelike morphinandienes and their diels-alder adducts. Opioid antagonists: structure activity relationships. Effect of fluorine substitution on the anti-HIV activity of dideoxynucleosides. Opiate antagonists and anti-HIV agents. Classical and nonclassical cannabinoids: mechanisms of action - brain binding. Cocaine receptor - design of ligands. Structural and functional similarities of opiate receptors of neural and immune origin. Immunomodulatory effects of chronic morphine treatment: pharmacologic and mechanistic studies. Morphine-induced immune modulation: does it predispose to HIV infection? A murine retrovirus model for studies of the role of cofactors and ethanol in AIDS development. Drug abuse and AIDS: causes for the connection. Immune function in heroin addicts and former heroin addicts in treatment: pre- and post-AIDS epidemic. Opioid peptides, receptors, and immune function.
*650 4$aReceptors, drug
*650 4$aAnaleptics
*650 4$aOpiates
*650 4$aAcquired immunodeficiency syndrome
*650 4$aNarcotics
*650 4$aCannabinoids
*650 4$aCocaine
*650 4$aMorphine
*650 4$aHeroin dependence
*650 4$aBiochemistry
*650 4$aPharmacology
*653  $aAIDS
*653  $aNarkotika
*653  $aKokain
*653  $aMorfin
*653  $aHeroin
*653  $aBiokemi
*653  $aFarmakologi
*653  $aImmunologi
*7001 $aPham, Phuong Thi Kim$eed.
*7001 $aRice, Kenner$eed.
*7101 $aNational Institute on Drug Abuse$0124050
*85640$uhttps://archives.drugabuse.gov/sites/default/files/monograph96.pdf
^